BankPlus Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
4,783
+32
+0.7% +$8.2K 0.55% 29
2026
Q2
$1.2M Buy
4,751
+118
+3% +$25.4K 0.54% 33
2026
Q1
$1.01M Buy
4,633
+442
+11% +$98K 0.52% 31
2025
Q4
$958K Sell
4,191
-156
-4% -$35.5K 0.53% 31
2025
Q3
$1.01M Buy
4,347
+144
+3% +$29.3K 0.59% 26
2025
Q2
$780K Buy
4,203
+92
+2% +$17.1K 0.52% 35
2025
Q1
$861K Sell
4,111
-33
-0.8% -$6.42K 0.63% 27
2024
Q4
$736K Buy
+4,144
New +$762K 0.55% 33

Other funds holding ABBV

BankPlus Wealth Management's ABBV Position: Q3 2026 in Review

BankPlus Wealth Management increased its AbbVie (ABBV) stake by 0.67% in Q3 2026, buying an estimated $8.2K and bringing the position to 4,783 shares worth $1.25M. The position accounts for 0.55% of the portfolio, ranked #29.

BankPlus Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BankPlus Wealth Management held 4,783 shares of AbbVie worth $1.25M as of Q3 2026.
  • BankPlus Wealth Management bought 32 AbbVie shares in Q3 2026, an estimated $8.2K.
  • AbbVie made up 0.55% of BankPlus Wealth Management's portfolio in Q3 2026, its #29 holding.
  • BankPlus Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.